Osteoporosis Clinical Trial
Official title:
In Vivo Discrimination of Hip Fracture With Quantitative Computed Tomography
Numerous geometric and bone mineral density (BMD) parameters can be derived from
quantitative computed tomography (QCT) images of the proximal femur analyzed using dedicated
software. The primary objective is to evaluate the contribution of QCT-image analysis to the
prediction of the osteoporotic hip fracture risk, as compared to the reference standard,
namely, dual energy X-ray absorptiometry (DXA).
Study hypothesis: For predicting osteoporotic hip fracture, findings from QCT images of the
proximal femur analyzed using dedicated software are superior over DXA measurements of
proximal femoral BMD.
Background Osteoporotic hip fractures exact an immense human and economic toll and therefore
constitute a major public health problem. Because their incidence increases exponentially
with age in both men and women, they will impose an increasing burden in the near future as
the population continues to age throughout the world. In addition to the direct costs of
fractures (hospitalisation and rehabilitation), the subsequent risks of death, functional
impairment, dependency, and institutionalization are increased as compared to same-age
individuals without fractures. Low BMD is the main risk factor for hip fracture and is
generally measured using DXA, which is the reference standard.
Objectives Our research project aims to identify QCT factors that predict osteoporotic hip
fracture. To this end, we will use image analysis software specially designed for proximal
femur evaluation to assess 3D QCT images of the proximal femur. Femoral BMD and geometry
parameters will be studied. This method has been validated experimentally. Our working
hypothesis is that it will prove superior over DXA (the reference standard) in predicting
osteoporotic Phip fractures.
Originality
The QCT-image analysis method investigated in our study is original, as there are no
commercially available tools for measuring proximal femur BMD on QCT images. This original
method grew out of 6 years of work conducted jointly at the Medical Physics Institute of the
Erlangen University and the Experimental Radiology Laboratory of the LARIBOISIERE-St-Louis
Research and Training Unit. Advantages of our method include 3D evaluation of the hip (with
measurement of the true volumetric density), evaluation of both BMD and bone geometry, and
separate evaluations of cortical and trabecular bone. DXA produces 2D images of the hip,
spine, or wrist that neither provide geometric data (except projected neck length) nor allow
separate analysis of cortical and trabecular bone.
We will use a case-control design to investigate postmenopausal patients with hip fracture
and female age-matched controls without hip fracture.
This research project focusing on age-related bone changes is part of a multidisciplinary
effort conducted by rheumatologists, radiologists, gerontologists, and orthopaedic surgeons.
It will provide new information for understanding fracture pathogenesis and optimising
prevention strategies in high-risk populations.
Study design We will compare geometric and BMD parameters at the proximal femur in women
with PFF and in age-matched women without PFF. This is a multicenter case-control study with
direct individual benefit. A diagnostic benefit exists for both the cases and the controls,
who will undergo a thorough physical evaluation including routine screening for factors
suggesting secondary osteoporosis, BMD measurements, and identification of risk factors for
fractures (e.g., impaired balance) to allow planning of appropriate primary prevention
(controls) or secondary prevention (cases). The therapeutic benefit will lie in advice
regarding diet and lifestyle, calcium and vitamin D supplementation, and bisphosphonate
therapy, as indicated by bone mass measurement results.
Recruitment procedure (see eligibility below)
1. Patients with PFF
Patients with PFF will be recruited at four centres:
- the orthopaedic surgery department of the LARIBOISIERE Teaching Hospital (Prof L.
SEDEL and Prof. R. NIZARD)
- the gerontology department at the Sainte-Périne hospital (Dr Roger)
- the orthopaedic surgery department of the St-ANTOINE Teaching Hospital (Prof Alain
SAUTET)
- the orthopaedic surgery department of the PANTIN Center (Dr Pascal BIZOT)
2. Controls The controls will be recruited at the same four centres, either among patients
referred for the diagnosis and prevention of age-related bone loss or among patients
admitted for reasons other than hip fracture.
Procedures, investigations, and sample collection
1. Clinical data Age, height, weight, personal and familial medical history, smoking
status, corticosteroids, treatment
2. Laboratory tests We will assay serum vitamin D levels, which are often low in women
older than 65 years. All vitamin D assays for the study will be done in the same run
(laboratory headed by Prof. Launay, LARIBOISIERE Teaching Hospital).
3. Bone mineral density (DXA) BMD will be measured suing a LUNAR DPX-L machine (Madison,
USA). BMD measurement by DXA is the reference standard for the diagnosis of
osteoporosis or osteopenia. BMD will be measured at the lumbar spine (L1 to L4) and
proximal femur.
4. Quantitative computed tomography QCT allows for separate measurements in cortical and
trabecular bone. Cortical bone will be evaluated at the proximal femur, and both BMD
and geometry will be measured. In addition to parameters characterizing cortical bone,
we will measure cancellous bone BMD and geometry. The methodology and the study
parameters will vary according to the measurement site. When designing the
investigation protocols, we sought the best trade-off between minimum radiation
exposure and maximum image quality .
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A | |
Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A |